1. Home
  2. HQL

as of 03-18-2026 9:42am EST

$16.57
$0.05
-0.30%
Stocks Finance Investment Managers Nasdaq

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.

Founded: 1992 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 490.5M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 116.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
11.56%
Dividend Payout Frequency: Quarterly
EPS: 0.79 EPS Growth: N/A
52 Week Low/High: $10.55 - $17.80 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: 21.03 Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered HQL Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 15 hours ago

AI Recommendation

hold
Model Accuracy: 72.22%
72.22%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: